Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended |
Mar. 31, 2015 | |
Entity Information [Line Items] | |
Entity Registrant Name | COLGATE PALMOLIVE CO |
Entity Central Index Key | 21665 |
Current Fiscal Year End Date | -19 |
Entity Well-known Seasoned Issuer | Yes |
Entity Voluntary Filers | No |
Entity Current Reporting Status | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Common Stock, Shares Outstanding | 904,569,917 |
Document Fiscal Year Focus | 2015 |
Document Fiscal Period Focus | Q1 |
Document Type | 10-Q |
Amendment Flag | FALSE |
Trading Symbol | CL |
Document Period End Date | 31-Mar-15 |
CONDENSED_CONSOLIDATED_STATEME
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) | 3 Months Ended | |||
In Millions, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | ||
Dividend | Dividend | |||
Net sales | $4,070 | $4,325 | ||
Cost of sales | 1,678 | 1,801 | ||
Gross profit | 2,392 | 2,524 | ||
Selling, general and administrative expenses | 1,450 | 1,544 | ||
Other (income) expense, net | 82 | 346 | ||
Operating profit | 860 | 634 | ||
Interest (income) expense, net | 8 | 7 | ||
Income before income taxes | 852 | 627 | ||
Provision for income taxes | 269 | 195 | ||
Net income including noncontrolling interests | 583 | 432 | ||
Less: Net income attributable to noncontrolling interests | 41 | 44 | ||
Net income attributable to Colgate-Palmolive Company | $542 | $388 | ||
Earnings per common share, basic (in dollars per share) | $0.60 | $0.42 | ||
Earnings per common share, diluted (in dollars per share) | $0.59 | $0.42 | ||
Dividends declared per common share (in dollars per share) | $0.74 | [1] | $0.70 | [1] |
Number of Dividends Declared Per Quarter | 2 | 2 | ||
[1] | Two dividends were declared in each period. |
CONDENSED_CONSOLIDATED_STATEME1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Net income including noncontrolling interests | $583 | $432 |
Other comprehensive income (loss), net of tax: | ||
Cumulative translation adjustments | -351 | -44 |
Retirement Plan and other retiree benefit adjustments | 13 | 13 |
Gains (losses) on available-for-sale securities | -1 | -56 |
Gains (losses) on cash flow hedges | 0 | 0 |
Total Other comprehensive income (loss), net of tax | -339 | -87 |
Total Comprehensive income including noncontrolling interests | 244 | 345 |
Less: Net income attributable to noncontrolling interests | 41 | 44 |
Less: Cumulative translation adjustments attributable to noncontrolling interests | 1 | -1 |
Total Comprehensive Income attributable to noncontrolling interests | 42 | 43 |
Total Comprehensive income attributable to Colgate-Palmolive Company | $202 | $302 |
CONDENSED_CONSOLIDATED_BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Millions, unless otherwise specified | ||
Current Assets | ||
Cash and cash equivalents | $859 | $1,089 |
Receivables (net of allowances of $58 and $54, respectively) | 1,611 | 1,552 |
Inventories | 1,350 | 1,382 |
Other current assets | 880 | 840 |
Total current assets | 4,700 | 4,863 |
Property, plant and equipment: | ||
Cost | 8,212 | 8,385 |
Less: Accumulated depreciation | -4,244 | -4,305 |
Property, plant and equipment, net | 3,968 | 4,080 |
Goodwill | 2,186 | 2,307 |
Other intangible assets, net | 1,356 | 1,413 |
Deferred income taxes | 79 | 76 |
Other assets | 867 | 720 |
Total assets | 13,156 | 13,459 |
Current Liabilities | ||
Notes and loans payable | 18 | 16 |
Current portion of long-term debt | 488 | 488 |
Accounts payable | 1,167 | 1,231 |
Accrued income taxes | 417 | 294 |
Other accruals | 2,233 | 1,917 |
Total current liabilities | 4,323 | 3,946 |
Long-term debt | 5,622 | 5,644 |
Deferred income taxes | 233 | 261 |
Other liabilities | 2,239 | 2,223 |
Total liabilities | 12,417 | 12,074 |
Shareholders' Equity | ||
Common stock | 1,466 | 1,466 |
Additional paid-in capital | 1,272 | 1,236 |
Retained earnings | 18,704 | 18,832 |
Accumulated other comprehensive income (loss) | -3,847 | -3,507 |
Unearned compensation | -13 | -20 |
Treasury stock, at cost | -17,122 | -16,862 |
Total Colgate-Palmolive Company shareholders' equity | 460 | 1,145 |
Noncontrolling interests | 279 | 240 |
Total shareholders' equity | 739 | 1,385 |
Total liabilities and shareholders' equity | $13,156 | $13,459 |
CONDENSED_CONSOLIDATED_BALANCE1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Millions, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $58 | $54 |
CONDENSED_CONSOLIDATED_STATEME2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Operating Activities | ||
Net income including noncontrolling interests | $583 | $432 |
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | ||
Depreciation and amortization | 114 | 108 |
Restructuring and termination benefits, net of cash | 57 | 45 |
Venezuela remeasurements charges | 0 | 266 |
Stock-based compensation expense | 32 | 34 |
Deferred income taxes | -22 | -21 |
Cash effects of changes in: | ||
Receivables | -150 | -77 |
Inventories | -23 | -67 |
Accounts payable and other accruals | 111 | 100 |
Other non-current assets and liabilities | 25 | 0 |
Net cash provided by operations | 727 | 820 |
Investing Activities | ||
Capital expenditures | -122 | -168 |
Purchases of marketable securities and investments | -252 | -151 |
Proceeds from sale of marketable securities and investments | 110 | 74 |
Payments for acquisitions, net of cash acquired | 0 | -25 |
Other | 7 | 21 |
Net cash used in investing activities | -257 | -249 |
Financing Activities | ||
Principal payments on debt | -2,171 | -1,938 |
Proceeds from issuance of debt | 2,105 | 2,960 |
Dividends paid | -329 | -316 |
Purchases of treasury shares | -374 | -453 |
Proceeds from exercise of stock options and excess tax benefits | 128 | 50 |
Net cash (used in) provided by financing activities | -641 | 303 |
Effect of exchange rate changes on Cash and cash equivalents | -59 | -41 |
Net (decrease) increase in Cash and cash equivalents | -230 | 833 |
Cash and cash equivalents at beginning of the period | 1,089 | 962 |
Cash and cash equivalents at end of the period | 859 | 1,795 |
Supplemental Cash Flow Information | ||
Income taxes paid | $164 | $171 |
Basis_of_Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation |
The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation. | |
For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission. |
Use_of_Estimates
Use of Estimates | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Use of Estimates | Use of Estimates |
Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales. |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2015 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements |
On April 7, 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03 “Simplifying the Presentation of Debt Issuance Costs,” which requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of related debt liability, consistent with debt discounts. Under current accounting standards, such costs are recorded as an asset. The new guidance is effective for the Company beginning January 1, 2016, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. | |
On February 18, 2015, the FASB issued ASU No. 2015-02 “Consolidation (Topic 810): Amendments to the Consolidation Analysis” that amends the current consolidation guidance. The amendments affect both the variable interest entity and voting interest entity consolidation models. The new guidance is effective for the Company beginning January 1, 2016, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. | |
On May 28, 2014, the FASB and the International Accounting Standards Board (“IASB”) issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09 “Revenue from Contracts with Customers” by the FASB, provides a single, comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures which are significantly more comprehensive than those in existing revenue standards. This new guidance is currently effective for the Company beginning January 1, 2017, with no early adoption permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements. |
Acquisitions_and_Divestitures
Acquisitions and Divestitures | 3 Months Ended |
Mar. 31, 2015 | |
Business Combinations [Abstract] | |
Acquisitions and Divestitures | Acquisitions and Divestitures |
Acquisition | |
On October 3, 2014, the Company acquired an oral care business in Myanmar for $62 in cash plus additional consideration contingent upon achievement of performance targets under a distribution services agreement. | |
Sale of Land in Mexico | |
On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America (the “Purchaser”) the Mexico City site on which its commercial operations, technology center and soap production facility were located. The sale price is payable in three installments. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The parties subsequently amended that agreement to extend the closing date and are in the process of negotiating an additional amendment. Under the existing agreement, the final installment of the purchase price is due upon the transfer of the property, which is subject to the Company’s satisfaction of certain closing conditions relating to site preparation by May 19, 2015. While these conditions are not expected to be fully satisfied by May 19, 2015, in which case the Purchaser has several options under the agreement (including termination and the return to it of the first two installments of the purchase price), based on the discussions to date, the Company believes that the transfer of the property is still likely to occur in 2015. The Company has reinvested the first two installments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months ended March 31, 2015 and 2014, the Company recorded $0 and $1 of pretax costs ($0 and $1 of aftertax costs), respectively, related to the sale. |
Restructuring_and_Related_Impl
Restructuring and Related Implementation Charges | 3 Months Ended | ||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||
Restructuring And Related Implementation Charges | Restructuring and Related Implementation Charges | ||||||||||||||||||||
In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses. | |||||||||||||||||||||
On October 23, 2014, the Company’s Board of Directors approved an expansion of the Global Growth and Efficiency Program (as expanded, the “2012 Restructuring Program”) to take advantage of additional savings opportunities. | |||||||||||||||||||||
Cumulative pretax charges related to the 2012 Restructuring Program, once all phases are approved and implemented, are estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax). Implementation of the 2012 Restructuring Program is expected to be substantially completed by December 31, 2016. These pretax charges are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (20%). Anticipated pretax charges for 2015 are expected to amount to approximately $330 to $385 ($245 to $285 aftertax). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures. | |||||||||||||||||||||
It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, by the end of 2016, the 2012 Restructuring Program will contribute a net reduction of approximately 2,000-2,500 positions from the Company’s global employee workforce. | |||||||||||||||||||||
For the three months ended March 31, 2015 and 2014, restructuring and implementation-related charges are reflected in the Condensed Consolidated Statements of Income as follows: | |||||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||
Cost of sales | $ | 4 | $ | 10 | |||||||||||||||||
Selling, general and administrative expenses | 18 | 17 | |||||||||||||||||||
Other (income) expense, net | 78 | 75 | |||||||||||||||||||
Total 2012 Restructuring Program charges, pretax | $ | 100 | $ | 102 | |||||||||||||||||
Total 2012 Restructuring Program charges, aftertax | $ | 67 | $ | 73 | |||||||||||||||||
Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. | |||||||||||||||||||||
Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments: | |||||||||||||||||||||
Program-to-date | |||||||||||||||||||||
Three Months Ended March 31, | Accumulated Charges | ||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||
North America | 18 | % | 9 | % | 11 | % | |||||||||||||||
Latin America | — | % | 4 | % | 3 | % | |||||||||||||||
Europe/South Pacific | 7 | % | 21 | % | 25 | % | |||||||||||||||
Asia | — | % | — | % | 1 | % | |||||||||||||||
Africa/Eurasia | 3 | % | 2 | % | 5 | % | |||||||||||||||
Hill’s Pet Nutrition | 4 | % | 8 | % | 8 | % | |||||||||||||||
Corporate | 68 | % | 56 | % | 47 | % | |||||||||||||||
Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $846 ($623 aftertax) in connection with the implementation of various projects as follows: | |||||||||||||||||||||
Cumulative Charges | |||||||||||||||||||||
as of March 31, 2015 | |||||||||||||||||||||
Employee-Related Costs | $ | 330 | |||||||||||||||||||
Incremental Depreciation | 57 | ||||||||||||||||||||
Asset Impairments | 2 | ||||||||||||||||||||
Other | 457 | ||||||||||||||||||||
Total | $ | 846 | |||||||||||||||||||
The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the extension of shared business services and streamlining of global functions; restructuring how the Company will provide future retirement benefits to substantially all of its U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the closing of the Morristown, New Jersey personal care facility. | |||||||||||||||||||||
The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals: | |||||||||||||||||||||
Three Months Ended March 31, 2015 | |||||||||||||||||||||
Employee-Related | Incremental | Asset | Other | Total | |||||||||||||||||
Costs | Depreciation | Impairments | |||||||||||||||||||
Balance at December 31, 2014 | $ | 85 | $ | — | $ | — | $ | 107 | $ | 192 | |||||||||||
Charges | 35 | 6 | — | 59 | 100 | ||||||||||||||||
Cash payments | (15 | ) | — | — | (26 | ) | (41 | ) | |||||||||||||
Charges against assets | (8 | ) | (6 | ) | — | — | (14 | ) | |||||||||||||
Foreign exchange | (5 | ) | — | — | (1 | ) | (6 | ) | |||||||||||||
Balance at March 31, 2015 | $ | 92 | $ | — | $ | — | $ | 139 | $ | 231 | |||||||||||
Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $8 for the three months ended March 31, 2015, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits). | |||||||||||||||||||||
Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets. | |||||||||||||||||||||
Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2015 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $12 and contract termination costs and charges resulting directly from exit activities of $3 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2015 are other exit costs of $44 related to the consolidation of facilities. |
Inventories
Inventories | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ||||||||
Inventories | Inventories | |||||||
Inventories by major class are as follows: | ||||||||
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
Raw materials and supplies | $ | 323 | $ | 349 | ||||
Work-in-process | 56 | 55 | ||||||
Finished goods | 971 | 978 | ||||||
Total Inventories | $ | 1,350 | $ | 1,382 | ||||
Shareholders_Equity
Shareholders' Equity | 3 Months Ended | |||||||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||
Stockholders' Equity | Shareholders’ Equity | |||||||||||||||||||||||||||
Changes in the components of Shareholders’ Equity for the three months ended March 31, 2015 are as follows: | ||||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | Noncontrolling | |||||||||||||||||||||||||||
Interests | ||||||||||||||||||||||||||||
Common | Additional | Unearned | Treasury | Retained | Accumulated | |||||||||||||||||||||||
Stock | Paid-in | Compensation | Stock | Earnings | Other | |||||||||||||||||||||||
Capital | Comprehensive | |||||||||||||||||||||||||||
Income (Loss) | ||||||||||||||||||||||||||||
Balance, December 31, 2014 | $ | 1,466 | $ | 1,236 | $ | (20 | ) | $ | (16,862 | ) | $ | 18,832 | $ | (3,507 | ) | $ | 240 | |||||||||||
Net income | 542 | 41 | ||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | (340 | ) | 1 | |||||||||||||||||||||||||
Dividends | (670 | ) | (3 | ) | ||||||||||||||||||||||||
Stock-based compensation expense | 32 | |||||||||||||||||||||||||||
Shares issued for stock options | 32 | 85 | ||||||||||||||||||||||||||
Shares issued for restricted stock awards | (29 | ) | 29 | |||||||||||||||||||||||||
Treasury stock acquired | (374 | ) | ||||||||||||||||||||||||||
Other | 1 | 7 | ||||||||||||||||||||||||||
Balance, March 31, 2015 | $ | 1,466 | $ | 1,272 | $ | (13 | ) | $ | (17,122 | ) | $ | 18,704 | $ | (3,847 | ) | $ | 279 | |||||||||||
Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,805 and $2,453 at March 31, 2015 and December 31, 2014, respectively, and unrecognized retirement plan and other retiree benefits costs of $1,051 and $1,064 at March 31, 2015 and December 31, 2014, respectively. |
Earnings_Per_Share
Earnings Per Share | 3 Months Ended | |||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||
Earnings Per Share | Earnings Per Share | |||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||
March 31, 2015 | March 31, 2014 | |||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares | Per | Net income attributable to Colgate-Palmolive Company | Shares | Per | |||||||||||||||||
(millions) | Share | (millions) | Share | |||||||||||||||||||
Basic EPS | $ | 542 | 907.7 | $ | 0.6 | $ | 388 | 919.5 | $ | 0.42 | ||||||||||||
Stock options and | 8.6 | 9.1 | ||||||||||||||||||||
restricted stock units | ||||||||||||||||||||||
Diluted EPS | $ | 542 | 916.3 | $ | 0.59 | $ | 388 | 928.6 | $ | 0.42 | ||||||||||||
For the three months ended March 31, 2015 and 2014, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,566,993 and 3,374,995, respectively. | ||||||||||||||||||||||
Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period. |
Other_Comprehensive_Income_Los
Other Comprehensive Income (Loss) | 3 Months Ended | ||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||
Equity [Abstract] | |||||||||||||||||
Other Comprehensive Income (Loss) | Other Comprehensive Income (Loss) | ||||||||||||||||
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2015 and 2014 were as follows: | |||||||||||||||||
2015 | 2014 | ||||||||||||||||
Pretax | Net of Tax | Pretax | Net of Tax | ||||||||||||||
Cumulative translation adjustments | $ | (340 | ) | $ | (352 | ) | $ | (39 | ) | $ | (43 | ) | |||||
Retirement plans and other retiree benefits: | |||||||||||||||||
Net actuarial gain (loss) and prior service costs arising during the period | (1 | ) | (1 | ) | 3 | 2 | |||||||||||
Amortization of net actuarial loss, transition and prior service costs (1) | 22 | 14 | 14 | 11 | |||||||||||||
Retirement plans and other retiree benefits adjustments | 21 | 13 | 17 | 13 | |||||||||||||
Available-for-sale securities: | |||||||||||||||||
Unrealized gains (losses) on available-for-sale securities (2) | (1 | ) | (1 | ) | (298 | ) | (194 | ) | |||||||||
Reclassification of (gains) losses into net earnings on available-for-sale securities (3) | — | — | 211 | 138 | |||||||||||||
Gains (losses) on available-for-sale securities | (1 | ) | (1 | ) | (87 | ) | (56 | ) | |||||||||
Cash flow hedges: | |||||||||||||||||
Unrealized gains (losses) on cash flow hedges | 6 | 4 | 2 | 1 | |||||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges (4) | (6 | ) | (4 | ) | (3 | ) | (1 | ) | |||||||||
Gains (losses) on cash flow hedges | — | — | (1 | ) | — | ||||||||||||
Total Other comprehensive income (loss) | $ | (320 | ) | $ | (340 | ) | $ | (110 | ) | $ | (86 | ) | |||||
(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details. | |||||||||||||||||
(2)For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014. | |||||||||||||||||
(3)Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||||
(4)These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||||
There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests. |
Retirement_Plans_and_Other_Ret
Retirement Plans and Other Retiree Benefits | 3 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ||||||||||||||||||||||||
Retirement Plans and Other Retiree Benefits | Retirement Plans and Other Retiree Benefits | |||||||||||||||||||||||
Components of Net periodic benefit cost for the three months ended March 31, 2015 and 2014 were as follows: | ||||||||||||||||||||||||
Pension Benefits | Other Retiree Benefits | |||||||||||||||||||||||
United States | International | |||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | 2015 | 2014 | |||||||||||||||||||
Service cost | $ | — | $ | — | $ | 5 | $ | 5 | $ | 4 | $ | 3 | ||||||||||||
Interest cost | 25 | 25 | 8 | 9 | 11 | 10 | ||||||||||||||||||
Expected return on plan assets | (29 | ) | (27 | ) | (8 | ) | (7 | ) | (1 | ) | — | |||||||||||||
Amortization of transition and prior service costs (credits) | — | — | — | 1 | — | — | ||||||||||||||||||
Amortization of actuarial loss (gain) | 12 | 8 | 3 | 1 | 7 | 4 | ||||||||||||||||||
Net periodic benefit cost | $ | 8 | $ | 6 | $ | 8 | $ | 9 | $ | 21 | $ | 17 | ||||||||||||
For the three months ended March 31, 2015 and March 31, 2014, the Company did not make any voluntary contributions to its U.S. postretirement plans. |
Contingencies
Contingencies | 3 Months Ended | |
Mar. 31, 2015 | ||
Loss Contingency [Abstract] | ||
Contingencies | Contingencies | |
As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. | ||
The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. | ||
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $200 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. | ||
Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year. | ||
Brazilian Matters | ||
There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”). | ||
The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $90. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process since October 2001. Numerous appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts. The Company intends to challenge these assessments vigorously. | ||
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously. | ||
In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $55, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company has been disputing the assessment within the internal revenue authority’s administrative appeals process. In November 2014, the Superior Chamber of Administrative Tax Appeals denied the Company’s most recent appeal. Further appeals are available both at the administrative level and within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously. | ||
Competition Matters | ||
The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues, as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate. | ||
European Competition Matters | ||
Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases fines, by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below. | ||
Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines: | ||
▪ | In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court. | |
▪ | In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court. | |
▪ | In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts. | |
▪ | In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) pursuant to a Business and Share Sale and Purchase Agreement (the “Sanex Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is entitled to indemnification for this fine under the Sanex Purchase Agreement and is seeking indemnification from Unilever. The Company is appealing both fines in the French courts. | |
Currently, formal claims of violations or statements of objections are pending against the Company as follows: | ||
▪ | In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices in the Belgian market. The defendants have initiated preliminary talks with the authority regarding a possible settlement. | |
▪ | In July 2014, the Greek competition law authority issued a statement of objections alleging the Company and its Greek subsidiary restricted parallel imports into Greece. The Company has responded to this statement of objections. | |
Since December 31, 2014, the following matter has been resolved: | ||
▪ | In March 2015, the French Supreme Court confirmed the French competition law authority’s March 2012 fine of the Company’s Hill’s French subsidiary in the amount of $7. | |
Australian Competition Matter | ||
In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra concentrated laundry detergents. The Company is defending these proceedings. Since the amount of any potential losses from these proceedings currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings. | ||
Talcum Powder Matters | ||
The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. The Company is challenging these cases vigorously. Nineteen cases filed against the Company have been dismissed and had final judgment entered in favor of the Company. In April 2015, an agreement in principle was reached to settle four individual cases following a trial and jury verdict in one of the cases in California against the Company and others. The amount of the settlement in principle is not material to the Company’s results of operations for the quarter ended March 31, 2015. | ||
There are 13 additional individual cases pending against the Company in state courts in Illinois, Maryland, New Jersey, New York and South Carolina. Some of these cases are expected to go to trial in 2015, although the Company may succeed in dismissing or otherwise resolving them. While the Company and its legal counsel believe these cases are without merit and intend to challenge them vigorously, there can be no assurances of the outcome at trial. Since the amount of any potential losses from these additional cases currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases. | ||
Segment_Information
Segment Information | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Segment Reporting [Abstract] | ||||||||
Segment Information | Segment Information | |||||||
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. | ||||||||
The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. | ||||||||
The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. | ||||||||
Net sales and Operating profit by segment were as follows: | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Net sales | ||||||||
Oral, Personal and Home Care | ||||||||
North America | $ | 789 | $ | 785 | ||||
Latin America | 1,087 | 1,152 | ||||||
Europe/South Pacific | 741 | 865 | ||||||
Asia | 661 | 672 | ||||||
Africa/Eurasia | 254 | 298 | ||||||
Total Oral, Personal and Home Care | 3,532 | 3,772 | ||||||
Pet Nutrition | 538 | 553 | ||||||
Total Net sales | $ | 4,070 | $ | 4,325 | ||||
Operating profit | ||||||||
Oral, Personal and Home Care | ||||||||
North America | $ | 218 | $ | 216 | ||||
Latin America | 308 | 290 | ||||||
Europe/South Pacific | 184 | 217 | ||||||
Asia | 193 | 193 | ||||||
Africa/Eurasia | 39 | 59 | ||||||
Total Oral, Personal and Home Care | 942 | 975 | ||||||
Pet Nutrition | 147 | 144 | ||||||
Corporate | (229 | ) | (485 | ) | ||||
Total Operating profit | $ | 860 | $ | 634 | ||||
Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). | ||||||||
For the three months ended March 31, 2015, Corporate Operating profit (loss) includes charges of $100 related to the 2012 Restructuring Program. For the three months ended March 31, 2014, Corporate Operating profit (loss) included charges of $102 related to the 2012 Restructuring Program, a charge of $266 related to the 2014 Venezuela Remeasurements and costs of $1 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures. |
Fair_Value_Measurements_and_Fi
Fair Value Measurements and Financial Instruments | 3 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Financial Instruments and Fair Value Measurements [Abstract] | ||||||||||||||||||||||||
Fair Value Measurements and Financial Instruments | Fair Value Measurements and Financial Instruments | |||||||||||||||||||||||
The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. | ||||||||||||||||||||||||
The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented. | ||||||||||||||||||||||||
The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months. | ||||||||||||||||||||||||
The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2015 and December 31, 2014: | ||||||||||||||||||||||||
Assets | Liabilities | |||||||||||||||||||||||
Fair Value | Account | Fair Value | ||||||||||||||||||||||
Account | ||||||||||||||||||||||||
Designated derivative instruments | 3/31/15 | 12/31/14 | 3/31/15 | 12/31/14 | ||||||||||||||||||||
Interest rate swap contracts | Other current assets | $ | 1 | $ | 1 | Other accruals | $ | — | $ | — | ||||||||||||||
Interest rate swap contracts | Other assets | 16 | 12 | Other liabilities | — | 2 | ||||||||||||||||||
Foreign currency contracts | Other current assets | 36 | 21 | Other accruals | 18 | 4 | ||||||||||||||||||
Foreign currency contracts | Other assets | 121 | 60 | Other liabilities | — | — | ||||||||||||||||||
Commodity contracts | Other current assets | — | — | Other accruals | 1 | 1 | ||||||||||||||||||
Total designated | $ | 174 | $ | 94 | $ | 19 | $ | 7 | ||||||||||||||||
Derivatives not designated | ||||||||||||||||||||||||
Foreign currency contracts | Other assets | $ | 13 | $ | 8 | Other liabilities | $ | — | $ | — | ||||||||||||||
Total not designated | $ | 13 | $ | 8 | $ | — | $ | — | ||||||||||||||||
Total derivative instruments | $ | 187 | $ | 102 | $ | 19 | $ | 7 | ||||||||||||||||
Other financial instruments | ||||||||||||||||||||||||
Marketable securities | Other current assets | $ | 250 | $ | 200 | |||||||||||||||||||
Available-for-sale securities | Other assets | 398 | 322 | |||||||||||||||||||||
Note receivable | Other current assets | 42 | 42 | |||||||||||||||||||||
Total other financial instruments | $ | 690 | $ | 564 | ||||||||||||||||||||
The carrying amount of cash, cash equivalents, accounts receivable, a note receivable and short-term debt approximated fair value as of March 31, 2015 and December 31, 2014. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2015 and December 31, 2014, was $6,463 and $6,346, respectively, and the related carrying value was $6,110 and $6,132, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation). | ||||||||||||||||||||||||
Fair Value Hedges | ||||||||||||||||||||||||
The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net. | ||||||||||||||||||||||||
Activity related to fair value hedges recorded during the three months ended March 31, 2015 and 2014 was as follows: | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Foreign | Interest | Foreign | Interest | |||||||||||||||||||||
Currency | Rate | Total | Currency | Rate | Total | |||||||||||||||||||
Contracts | Swaps | Contracts | Swaps | |||||||||||||||||||||
Notional Value at March 31, | $ | 1,213 | $ | 1,438 | $ | 2,651 | $ | 681 | $ | 1,688 | $ | 2,369 | ||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) on derivative | 2 | 6 | 8 | 2 | (10 | ) | (8 | ) | ||||||||||||||||
Gain (loss) on hedged items | (2 | ) | (6 | ) | (8 | ) | (2 | ) | 10 | 8 | ||||||||||||||
Cash Flow Hedges | ||||||||||||||||||||||||
All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. | ||||||||||||||||||||||||
Activity related to cash flow hedges recorded during the three months ended March 31, 2015 and 2014 was as follows: | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Foreign | Commodity | Foreign | Commodity | |||||||||||||||||||||
Currency | Contracts | Total | Currency | Contracts | Total | |||||||||||||||||||
Contracts | Contracts | |||||||||||||||||||||||
Notional Value at March 31, | $ | 595 | $ | 12 | $ | 607 | $ | 401 | $ | 15 | $ | 416 | ||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) recognized in OCI | 7 | (1 | ) | 6 | — | 2 | 2 | |||||||||||||||||
Gain (loss) reclassified into Cost of sales | 7 | (1 | ) | 6 | 2 | 1 | 3 | |||||||||||||||||
The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months. | ||||||||||||||||||||||||
Net Investment Hedges | ||||||||||||||||||||||||
The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items. | ||||||||||||||||||||||||
Activity related to net investment hedges recorded during the three months ended March 31, 2015 and 2014 was as follows: | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Foreign | Foreign | Foreign | Foreign | |||||||||||||||||||||
Currency | Currency | Total | Currency | Currency | Total | |||||||||||||||||||
Contracts | Debt | Contracts | Debt | |||||||||||||||||||||
Notional Value at March 31, | $ | 768 | $ | 273 | $ | 1,041 | $ | 680 | $ | 256 | $ | 936 | ||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) on instruments | 62 | 27 | 89 | — | 1 | 1 | ||||||||||||||||||
Gain (loss) on hedged items | (62 | ) | (27 | ) | (89 | ) | 1 | (1 | ) | — | ||||||||||||||
Derivatives Not Designated as Hedging Instruments | ||||||||||||||||||||||||
Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. | ||||||||||||||||||||||||
Activity related to this contract during the three months ended March 31, 2015 and 2014 was as follows: | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Cross-currency | Cross-currency | |||||||||||||||||||||||
Swap | Swap | |||||||||||||||||||||||
Notional Value at March 31, | $ | 102 | $ | 96 | ||||||||||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) on instrument | 5 | (1 | ) | |||||||||||||||||||||
Gain (loss) on hedged item | (5 | ) | 1 | |||||||||||||||||||||
Other Financial Instruments | ||||||||||||||||||||||||
Other financial instruments are classified as Other current assets or Other assets. | ||||||||||||||||||||||||
Other financial instruments classified as Other current assets include marketable securities and a fixed interest rate note receivable. Marketable securities consist of bank deposits of $217 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $33. The long-term portion of these bonds in the amount of $398 is included in Other assets. | ||||||||||||||||||||||||
Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and bolivar denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of March 31, 2015, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds was $72 and $359, respectively. These bonds are considered available-for-sale securities and, as noted above, the long-term portion in the amount of $398 is included in Other assets. | ||||||||||||||||||||||||
The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months ended March 31, 2015 and 2014: | ||||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Beginning balance as of January 1, | $ | 399 | $ | 685 | ||||||||||||||||||||
Unrealized gain (loss) on investment | (1 | ) | (298 | ) | ||||||||||||||||||||
Purchases and sales during the period | 33 | 54 | ||||||||||||||||||||||
Ending balance as of March 31, | $ | 431 | $ | 441 | ||||||||||||||||||||
Unrealized loss on investment for the three months ended March 31, 2014 consisted primarily of a charge of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014. | ||||||||||||||||||||||||
For further information regarding Venezuela, refer to Note 14, Venezuela. |
Venezuela
Venezuela | 3 Months Ended |
Mar. 31, 2015 | |
Foreign Currency [Abstract] | |
Venezuela | Venezuela |
Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income. | |
In February 2015, the Venezuelan government implemented changes in Venezuela’s foreign exchange regime. While the official exchange rate, as determined by the National Center for Foreign Commerce (“CENCOEX”), remains at 6.30 bolivares per dollar and the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market, now known as SICAD, is unchanged, the SICAD II market was eliminated and a new, alternative currency market, the Foreign Exchange Marginal System (“SIMADI”), was created and became operational with a floating exchange rate determined by market participants. | |
The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is currently the SICAD rate. During the quarter ended March 31, 2015, the SICAD rate did not revalue, remaining at 12.00 bolivares per dollar as of March 31, 2015. | |
During the quarter ended March 31, 2014, the Company incurred pretax losses of $266 ($174 aftertax losses, or $0.19 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD rate. Included in the remeasurement losses were charges related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remained at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD currency market but remained at the official exchange rate, resulting in an impairment in the fair value of the bonds. | |
CP Venezuela funds its requirements for imported goods through a combination of U.S. dollars obtained from CENCOEX and intercompany borrowings. Because most of the products in CP Venezuela’s portfolio have been designated as “essential” by the Venezuelan government, CP Venezuela’s access to U.S. dollars at the official rate of 6.30 bolivares per dollar has generally been sufficient to settle most of its U.S. dollar obligations for imported materials and the gains related to such transactions are recorded when the funds are authorized by CENCOEX and the liabilities are paid. | |
Although the SIMADI market was accessible to CP Venezuela, it did not participate in the market through March 31, 2015. Since its inception, the volume of transactions in the SIMADI market has been very limited and the exchange rate at March 31, 2015 was 192.95 bolivares per dollar. | |
For the three months ended March 31, 2015, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At March 31, 2015, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD rate, was $589. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated net non-monetary assets were $302 at March 31, 2015 and included $234 of fixed assets that could be subject to impairment if CP Venezuela is not able to implement further price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars from CENCOEX or the SICAD market to fund imports. | |
Additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing, payments, profits or imports or other governmental actions or continued or increased labor unrest would further negatively affect the Company’s business in Venezuela and the Company’s ability to effectively make key operational decisions in regard to its Venezuelan operations, both of which could result in an impairment of the Company’s investment in CP Venezuela. At March 31, 2015, the Company’s total investment in CP Venezuela was $987, which included intercompany payables of CP Venezuela. |
Restructuring_and_Related_Impl1
Restructuring and Related Implementation Charges (Tables) | 3 Months Ended | ||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||
Schedule Of Restructuring And Related Costs | For the three months ended March 31, 2015 and 2014, restructuring and implementation-related charges are reflected in the Condensed Consolidated Statements of Income as follows: | ||||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||
Cost of sales | $ | 4 | $ | 10 | |||||||||||||||||
Selling, general and administrative expenses | 18 | 17 | |||||||||||||||||||
Other (income) expense, net | 78 | 75 | |||||||||||||||||||
Total 2012 Restructuring Program charges, pretax | $ | 100 | $ | 102 | |||||||||||||||||
Total 2012 Restructuring Program charges, aftertax | $ | 67 | $ | 73 | |||||||||||||||||
Schedule Of Percent Of Total Restructuring Charges Related To Segment For The Period | Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments: | ||||||||||||||||||||
Program-to-date | |||||||||||||||||||||
Three Months Ended March 31, | Accumulated Charges | ||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||
North America | 18 | % | 9 | % | 11 | % | |||||||||||||||
Latin America | — | % | 4 | % | 3 | % | |||||||||||||||
Europe/South Pacific | 7 | % | 21 | % | 25 | % | |||||||||||||||
Asia | — | % | — | % | 1 | % | |||||||||||||||
Africa/Eurasia | 3 | % | 2 | % | 5 | % | |||||||||||||||
Hill’s Pet Nutrition | 4 | % | 8 | % | 8 | % | |||||||||||||||
Corporate | 68 | % | 56 | % | 47 | % | |||||||||||||||
Schedule Of Restructuring And Related Costs Incurred To Date | Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $846 ($623 aftertax) in connection with the implementation of various projects as follows: | ||||||||||||||||||||
Cumulative Charges | |||||||||||||||||||||
as of March 31, 2015 | |||||||||||||||||||||
Employee-Related Costs | $ | 330 | |||||||||||||||||||
Incremental Depreciation | 57 | ||||||||||||||||||||
Asset Impairments | 2 | ||||||||||||||||||||
Other | 457 | ||||||||||||||||||||
Total | $ | 846 | |||||||||||||||||||
Schedule Of Restructuring Reserve By Type Of Cost | The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals: | ||||||||||||||||||||
Three Months Ended March 31, 2015 | |||||||||||||||||||||
Employee-Related | Incremental | Asset | Other | Total | |||||||||||||||||
Costs | Depreciation | Impairments | |||||||||||||||||||
Balance at December 31, 2014 | $ | 85 | $ | — | $ | — | $ | 107 | $ | 192 | |||||||||||
Charges | 35 | 6 | — | 59 | 100 | ||||||||||||||||
Cash payments | (15 | ) | — | — | (26 | ) | (41 | ) | |||||||||||||
Charges against assets | (8 | ) | (6 | ) | — | — | (14 | ) | |||||||||||||
Foreign exchange | (5 | ) | — | — | (1 | ) | (6 | ) | |||||||||||||
Balance at March 31, 2015 | $ | 92 | $ | — | $ | — | $ | 139 | $ | 231 | |||||||||||
Inventories_Tables
Inventories (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ||||||||
Inventories By Major Class | Inventories by major class are as follows: | |||||||
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
Raw materials and supplies | $ | 323 | $ | 349 | ||||
Work-in-process | 56 | 55 | ||||||
Finished goods | 971 | 978 | ||||||
Total Inventories | $ | 1,350 | $ | 1,382 | ||||
Shareholders_Equity_Tables
Shareholders' Equity (Tables) | 3 Months Ended | |||||||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||
Shareholders' Equity | Changes in the components of Shareholders’ Equity for the three months ended March 31, 2015 are as follows: | |||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | Noncontrolling | |||||||||||||||||||||||||||
Interests | ||||||||||||||||||||||||||||
Common | Additional | Unearned | Treasury | Retained | Accumulated | |||||||||||||||||||||||
Stock | Paid-in | Compensation | Stock | Earnings | Other | |||||||||||||||||||||||
Capital | Comprehensive | |||||||||||||||||||||||||||
Income (Loss) | ||||||||||||||||||||||||||||
Balance, December 31, 2014 | $ | 1,466 | $ | 1,236 | $ | (20 | ) | $ | (16,862 | ) | $ | 18,832 | $ | (3,507 | ) | $ | 240 | |||||||||||
Net income | 542 | 41 | ||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | (340 | ) | 1 | |||||||||||||||||||||||||
Dividends | (670 | ) | (3 | ) | ||||||||||||||||||||||||
Stock-based compensation expense | 32 | |||||||||||||||||||||||||||
Shares issued for stock options | 32 | 85 | ||||||||||||||||||||||||||
Shares issued for restricted stock awards | (29 | ) | 29 | |||||||||||||||||||||||||
Treasury stock acquired | (374 | ) | ||||||||||||||||||||||||||
Other | 1 | 7 | ||||||||||||||||||||||||||
Balance, March 31, 2015 | $ | 1,466 | $ | 1,272 | $ | (13 | ) | $ | (17,122 | ) | $ | 18,704 | $ | (3,847 | ) | $ | 279 | |||||||||||
Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,805 and $2,453 at March 31, 2015 and December 31, 2014, respectively, and unrecognized retirement plan and other retiree benefits costs of $1,051 and $1,064 at March 31, 2015 and December 31, 2014, respectively. |
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 3 Months Ended | |||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | ||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||
March 31, 2015 | March 31, 2014 | |||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares | Per | Net income attributable to Colgate-Palmolive Company | Shares | Per | |||||||||||||||||
(millions) | Share | (millions) | Share | |||||||||||||||||||
Basic EPS | $ | 542 | 907.7 | $ | 0.6 | $ | 388 | 919.5 | $ | 0.42 | ||||||||||||
Stock options and | 8.6 | 9.1 | ||||||||||||||||||||
restricted stock units | ||||||||||||||||||||||
Diluted EPS | $ | 542 | 916.3 | $ | 0.59 | $ | 388 | 928.6 | $ | 0.42 | ||||||||||||
For the three months ended March 31, 2015 and 2014, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,566,993 and 3,374,995, respectively. |
Other_Comprehensive_Income_Los1
Other Comprehensive Income (Loss) (Tables) | 3 Months Ended | ||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||
Equity [Abstract] | |||||||||||||||||
Schedule of Comprehensive Income (Loss) | Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2015 and 2014 were as follows: | ||||||||||||||||
2015 | 2014 | ||||||||||||||||
Pretax | Net of Tax | Pretax | Net of Tax | ||||||||||||||
Cumulative translation adjustments | $ | (340 | ) | $ | (352 | ) | $ | (39 | ) | $ | (43 | ) | |||||
Retirement plans and other retiree benefits: | |||||||||||||||||
Net actuarial gain (loss) and prior service costs arising during the period | (1 | ) | (1 | ) | 3 | 2 | |||||||||||
Amortization of net actuarial loss, transition and prior service costs (1) | 22 | 14 | 14 | 11 | |||||||||||||
Retirement plans and other retiree benefits adjustments | 21 | 13 | 17 | 13 | |||||||||||||
Available-for-sale securities: | |||||||||||||||||
Unrealized gains (losses) on available-for-sale securities (2) | (1 | ) | (1 | ) | (298 | ) | (194 | ) | |||||||||
Reclassification of (gains) losses into net earnings on available-for-sale securities (3) | — | — | 211 | 138 | |||||||||||||
Gains (losses) on available-for-sale securities | (1 | ) | (1 | ) | (87 | ) | (56 | ) | |||||||||
Cash flow hedges: | |||||||||||||||||
Unrealized gains (losses) on cash flow hedges | 6 | 4 | 2 | 1 | |||||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges (4) | (6 | ) | (4 | ) | (3 | ) | (1 | ) | |||||||||
Gains (losses) on cash flow hedges | — | — | (1 | ) | — | ||||||||||||
Total Other comprehensive income (loss) | $ | (320 | ) | $ | (340 | ) | $ | (110 | ) | $ | (86 | ) | |||||
(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details. | |||||||||||||||||
(2)For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014. | |||||||||||||||||
(3)Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||||
(4)These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details. | |||||||||||||||||
Retirement_Plans_and_Other_Ret1
Retirement Plans and Other Retiree Benefits (Tables) | 3 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ||||||||||||||||||||||||
Components Of Net Periodic Benefit Cost | Components of Net periodic benefit cost for the three months ended March 31, 2015 and 2014 were as follows: | |||||||||||||||||||||||
Pension Benefits | Other Retiree Benefits | |||||||||||||||||||||||
United States | International | |||||||||||||||||||||||
Three Months Ended March 31, | ||||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | 2015 | 2014 | |||||||||||||||||||
Service cost | $ | — | $ | — | $ | 5 | $ | 5 | $ | 4 | $ | 3 | ||||||||||||
Interest cost | 25 | 25 | 8 | 9 | 11 | 10 | ||||||||||||||||||
Expected return on plan assets | (29 | ) | (27 | ) | (8 | ) | (7 | ) | (1 | ) | — | |||||||||||||
Amortization of transition and prior service costs (credits) | — | — | — | 1 | — | — | ||||||||||||||||||
Amortization of actuarial loss (gain) | 12 | 8 | 3 | 1 | 7 | 4 | ||||||||||||||||||
Net periodic benefit cost | $ | 8 | $ | 6 | $ | 8 | $ | 9 | $ | 21 | $ | 17 | ||||||||||||
Segment_Information_Tables
Segment Information (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Segment Reporting [Abstract] | ||||||||
Net Sales and Operating Profit by Segment | Net sales and Operating profit by segment were as follows: | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Net sales | ||||||||
Oral, Personal and Home Care | ||||||||
North America | $ | 789 | $ | 785 | ||||
Latin America | 1,087 | 1,152 | ||||||
Europe/South Pacific | 741 | 865 | ||||||
Asia | 661 | 672 | ||||||
Africa/Eurasia | 254 | 298 | ||||||
Total Oral, Personal and Home Care | 3,532 | 3,772 | ||||||
Pet Nutrition | 538 | 553 | ||||||
Total Net sales | $ | 4,070 | $ | 4,325 | ||||
Operating profit | ||||||||
Oral, Personal and Home Care | ||||||||
North America | $ | 218 | $ | 216 | ||||
Latin America | 308 | 290 | ||||||
Europe/South Pacific | 184 | 217 | ||||||
Asia | 193 | 193 | ||||||
Africa/Eurasia | 39 | 59 | ||||||
Total Oral, Personal and Home Care | 942 | 975 | ||||||
Pet Nutrition | 147 | 144 | ||||||
Corporate | (229 | ) | (485 | ) | ||||
Total Operating profit | $ | 860 | $ | 634 | ||||
Fair_Value_Measurements_and_Fi1
Fair Value Measurements and Financial Instruments (Tables) | 3 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Financial Instruments and Fair Value Measurements [Abstract] | ||||||||||||||||||||||||
Schedule of derivative instruments | The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2015 and December 31, 2014: | |||||||||||||||||||||||
Assets | Liabilities | |||||||||||||||||||||||
Fair Value | Account | Fair Value | ||||||||||||||||||||||
Account | ||||||||||||||||||||||||
Designated derivative instruments | 3/31/15 | 12/31/14 | 3/31/15 | 12/31/14 | ||||||||||||||||||||
Interest rate swap contracts | Other current assets | $ | 1 | $ | 1 | Other accruals | $ | — | $ | — | ||||||||||||||
Interest rate swap contracts | Other assets | 16 | 12 | Other liabilities | — | 2 | ||||||||||||||||||
Foreign currency contracts | Other current assets | 36 | 21 | Other accruals | 18 | 4 | ||||||||||||||||||
Foreign currency contracts | Other assets | 121 | 60 | Other liabilities | — | — | ||||||||||||||||||
Commodity contracts | Other current assets | — | — | Other accruals | 1 | 1 | ||||||||||||||||||
Total designated | $ | 174 | $ | 94 | $ | 19 | $ | 7 | ||||||||||||||||
Derivatives not designated | ||||||||||||||||||||||||
Foreign currency contracts | Other assets | $ | 13 | $ | 8 | Other liabilities | $ | — | $ | — | ||||||||||||||
Total not designated | $ | 13 | $ | 8 | $ | — | $ | — | ||||||||||||||||
Total derivative instruments | $ | 187 | $ | 102 | $ | 19 | $ | 7 | ||||||||||||||||
Other financial instruments | ||||||||||||||||||||||||
Marketable securities | Other current assets | $ | 250 | $ | 200 | |||||||||||||||||||
Available-for-sale securities | Other assets | 398 | 322 | |||||||||||||||||||||
Note receivable | Other current assets | 42 | 42 | |||||||||||||||||||||
Total other financial instruments | $ | 690 | $ | 564 | ||||||||||||||||||||
Activity related to fair value hedges | Activity related to fair value hedges recorded during the three months ended March 31, 2015 and 2014 was as follows: | |||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Foreign | Interest | Foreign | Interest | |||||||||||||||||||||
Currency | Rate | Total | Currency | Rate | Total | |||||||||||||||||||
Contracts | Swaps | Contracts | Swaps | |||||||||||||||||||||
Notional Value at March 31, | $ | 1,213 | $ | 1,438 | $ | 2,651 | $ | 681 | $ | 1,688 | $ | 2,369 | ||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) on derivative | 2 | 6 | 8 | 2 | (10 | ) | (8 | ) | ||||||||||||||||
Gain (loss) on hedged items | (2 | ) | (6 | ) | (8 | ) | (2 | ) | 10 | 8 | ||||||||||||||
Activity related to cash flow hedges | Activity related to cash flow hedges recorded during the three months ended March 31, 2015 and 2014 was as follows: | |||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Foreign | Commodity | Foreign | Commodity | |||||||||||||||||||||
Currency | Contracts | Total | Currency | Contracts | Total | |||||||||||||||||||
Contracts | Contracts | |||||||||||||||||||||||
Notional Value at March 31, | $ | 595 | $ | 12 | $ | 607 | $ | 401 | $ | 15 | $ | 416 | ||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) recognized in OCI | 7 | (1 | ) | 6 | — | 2 | 2 | |||||||||||||||||
Gain (loss) reclassified into Cost of sales | 7 | (1 | ) | 6 | 2 | 1 | 3 | |||||||||||||||||
Activity related to net investment hedges | Activity related to net investment hedges recorded during the three months ended March 31, 2015 and 2014 was as follows: | |||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Foreign | Foreign | Foreign | Foreign | |||||||||||||||||||||
Currency | Currency | Total | Currency | Currency | Total | |||||||||||||||||||
Contracts | Debt | Contracts | Debt | |||||||||||||||||||||
Notional Value at March 31, | $ | 768 | $ | 273 | $ | 1,041 | $ | 680 | $ | 256 | $ | 936 | ||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) on instruments | 62 | 27 | 89 | — | 1 | 1 | ||||||||||||||||||
Gain (loss) on hedged items | (62 | ) | (27 | ) | (89 | ) | 1 | (1 | ) | — | ||||||||||||||
Activity related to derivatives not designated as hedging instruments | Activity related to this contract during the three months ended March 31, 2015 and 2014 was as follows: | |||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Cross-currency | Cross-currency | |||||||||||||||||||||||
Swap | Swap | |||||||||||||||||||||||
Notional Value at March 31, | $ | 102 | $ | 96 | ||||||||||||||||||||
Three months ended March 31: | ||||||||||||||||||||||||
Gain (loss) on instrument | 5 | (1 | ) | |||||||||||||||||||||
Gain (loss) on hedged item | (5 | ) | 1 | |||||||||||||||||||||
Reconciliation of the Venezuelan investments at fair value | The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months ended March 31, 2015 and 2014: | |||||||||||||||||||||||
2015 | 2014 | |||||||||||||||||||||||
Beginning balance as of January 1, | $ | 399 | $ | 685 | ||||||||||||||||||||
Unrealized gain (loss) on investment | (1 | ) | (298 | ) | ||||||||||||||||||||
Purchases and sales during the period | 33 | 54 | ||||||||||||||||||||||
Ending balance as of March 31, | $ | 431 | $ | 441 | ||||||||||||||||||||
Acquisitions_and_Divestitures_
Acquisitions and Divestitures (Details) (USD $) | 3 Months Ended | 0 Months Ended | |||
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Sep. 30, 2012 | Sep. 30, 2011 | Oct. 03, 2014 |
MEXICO | |||||
Sale of Land in Mexico [Abstract] | |||||
First Installment received from the sale of land in Mexico | $24 | ||||
Second Installment received from the sale of land in Mexico | 36 | ||||
Pretax costs related to sale of land | 0 | 1 | |||
Aftertax costs related to sale of land | 0 | 1 | |||
Oral Care Member | MYANMAR | |||||
Business Acquisition [Line Items] | |||||
Cash consideration for acquisition of business | $62 |
Restructuring_and_Related_Impl2
Restructuring and Related Implementation Charges (Details) (Two Thousand Twelve Restructuring Program [Member], USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2012 | Mar. 31, 2015 |
Restructuring Cost and Reserve [Line Items] | ||
Duration Of The Restructuring Program | 4 years | |
Expected Percent Of Total Charges Resulting In Cash Expenditure | 75.00% | |
Employee-Related Costs [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category | 50.00% | |
Incremental Depreciation And Asset Impairment [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category | 10.00% | |
Charges Resulting Directly From Exit Activities [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category | 20.00% | |
Implementation Of New Strategies [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category | 20.00% | |
Pet Nutrition [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 10.00% | |
Corporate, Non-Segment [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 40.00% | |
North America [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 15.00% | |
Europe/South Pacific [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 20.00% | |
Latin America [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 5.00% | |
Asia [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 5.00% | |
Africa/Eurasia [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program | 5.00% | |
Expected Completion Date 2016 [Member] | Minimum [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Program Expected Cost Before Tax | $1,285 | |
Restructuring Program Expected Cost After Tax | 950 | |
Restructuring and Related Cost, Positions Eliminated [Abstract] | ||
Restructuring And Related Cost, Expected Number Of Positions Eliminated | 2,000 | |
Expected Completion Date 2016 [Member] | Maximum [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Program Expected Cost Before Tax | 1,435 | |
Restructuring Program Expected Cost After Tax | 1,050 | |
Restructuring and Related Cost, Positions Eliminated [Abstract] | ||
Restructuring And Related Cost, Expected Number Of Positions Eliminated | 2,500 | |
Expected Completion Date December 2015 [Member] | Minimum [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Program Expected Cost Before Tax | 330 | |
Restructuring Program Expected Cost After Tax | 245 | |
Expected Completion Date December 2015 [Member] | Maximum [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring Program Expected Cost Before Tax | 385 | |
Restructuring Program Expected Cost After Tax | $285 |
Restructuring_and_Related_Impl3
Restructuring and Related Implementation Charges (Details 1) (Two Thousand Twelve Restructuring Program [Member], USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Restructuring Cost and Reserve [Line Items] | ||
Pretax Charges Related To The Restructuring Program | $100 | $102 |
Aftertax Charges Related To The Restructuring Program | 67 | 73 |
Cost of Sales [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Pretax Charges Related To The Restructuring Program | 4 | 10 |
Selling, General and Administrative Expenses [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Pretax Charges Related To The Restructuring Program | 18 | 17 |
Other (Income) Expense, Net [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Pretax Charges Related To The Restructuring Program | $78 | $75 |
Restructuring_and_Related_Impl4
Restructuring and Related Implementation Charges (Details 2) (Two Thousand Twelve Restructuring Program [Member]) | 3 Months Ended | 30 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2015 | |
Pet Nutrition [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 4.00% | 8.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 8.00% | ||
Corporate, Non-Segment [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 68.00% | 56.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 47.00% | ||
North America [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 18.00% | 9.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 11.00% | ||
Latin America [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 0.00% | 4.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 3.00% | ||
Europe/South Pacific [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 7.00% | 21.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 25.00% | ||
Asia [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 0.00% | 0.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 1.00% | ||
Africa/Eurasia [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Percent Of Total Restructuring Charges Related To Segment For The Period | 3.00% | 2.00% | |
Percent Of Restructuring Charges Related to Segment Program To Date | 5.00% |
Restructuring_and_Related_Impl5
Restructuring and Related Implementation Charges (Details 3) (Two Thousand Twelve Restructuring Program [Member], USD $) | Mar. 31, 2015 |
In Millions, unless otherwise specified | |
Restructuring Cost and Reserve [Line Items] | |
Pretax Charges Related To The Restructuring Program To Date | $846 |
Aftertax Charges Related To The Restructuring Program To Date | 623 |
Employee-Related Costs [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Pretax Charges Related To The Restructuring Program To Date | 330 |
Incremental Depreciation [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Pretax Charges Related To The Restructuring Program To Date | 57 |
Asset Impairment [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Pretax Charges Related To The Restructuring Program To Date | 2 |
Other Restructuring [Member] | |
Restructuring Cost and Reserve [Line Items] | |
Pretax Charges Related To The Restructuring Program To Date | $457 |
Restructuring_and_Related_Impl6
Restructuring and Related Implementation Charges (Details 4) (Two Thousand Twelve Restructuring Program [Member], USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Restructuring Cost and Reserve [Line Items] | ||
Beginning Balance | $192 | |
Charges | 100 | 102 |
Cash payments | -41 | |
Charges against assets | -14 | |
Foreign exchange | -6 | |
Ending Balance | 231 | |
Employee-Related Costs [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Beginning Balance | 85 | |
Charges | 35 | |
Cash payments | -15 | |
Charges against assets | -8 | |
Foreign exchange | -5 | |
Ending Balance | 92 | |
Incremental Depreciation [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Beginning Balance | 0 | |
Charges | 6 | |
Cash payments | 0 | |
Charges against assets | -6 | |
Foreign exchange | 0 | |
Ending Balance | 0 | |
Asset Impairment [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Beginning Balance | 0 | |
Charges | 0 | |
Cash payments | 0 | |
Charges against assets | 0 | |
Foreign exchange | 0 | |
Ending Balance | 0 | |
Other Restructuring [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Beginning Balance | 107 | |
Charges | 59 | |
Cash payments | -26 | |
Charges against assets | 0 | |
Foreign exchange | -1 | |
Ending Balance | 139 | |
Third Party Incremental Cost [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges | 12 | |
Contract Termination [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges | 3 | |
Land And Building [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Charges | $44 |
Inventories_Details
Inventories (Details) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Millions, unless otherwise specified | ||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ||
Raw materials and supplies | $323 | $349 |
Work-in-process | 56 | 55 |
Finished goods | 971 | 978 |
Total Inventories | $1,350 | $1,382 |
Shareholders_Equity_Details
Shareholders' Equity (Details) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 |
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | $1,385 | ||
Net income | 583 | 432 | |
Other comprehensive income, net of tax | -339 | -87 | |
Ending balance | 739 | ||
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | 2,805 | 2,453 | |
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax | 1,051 | 1,064 | |
Common Stock [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | 1,466 | ||
Ending balance | 1,466 | 1,466 | |
Additional Paid-In Capital [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | 1,236 | ||
Stock-based compensation expense | 32 | ||
Shares issued for stock options | 32 | ||
Stock issued for restricted stock awards | -29 | ||
Other | 1 | ||
Ending balance | 1,272 | ||
Unearned Compensation [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | -20 | ||
Other | 7 | ||
Ending balance | -13 | ||
Treasury Stock [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | -16,862 | ||
Shares issued for stock options | 85 | ||
Stock issued for restricted stock awards | 29 | ||
Treasury stock acquired | -374 | ||
Ending balance | -17,122 | ||
Retained Earnings [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | 18,832 | ||
Net income | 542 | ||
Dividends | -670 | ||
Ending balance | 18,704 | ||
Accumulated Other Comprehensive Income (Loss) [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | -3,507 | ||
Other comprehensive income, net of tax | -340 | ||
Ending balance | -3,847 | ||
Noncontrolling Interests [Member] | |||
Changes in Shareholders' Equity [Roll Forward] | |||
Beginning balance | 240 | ||
Net income | 41 | ||
Other comprehensive income, net of tax | 1 | ||
Dividends | -3 | ||
Ending balance | $279 |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | |
In Millions, except Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Earnings Per Share Reconciliation [Abstract] | ||
Net income attributable to Colgate-Palmolive Company, Basic | $542 | $388 |
Net income attributable to Colgate-Palmolive Company, Diluted | $542 | $388 |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | ||
Basic EPS (in shares) | 907,700,000 | 919,500,000 |
Stock options and restricted stock (in shares) | 8,600,000 | 9,100,000 |
Diluted EPS (in shares) | 916,300,000 | 928,600,000 |
Earnings Per Share, Basic and Diluted [Abstract] | ||
Earnings Per Share, Basic | $0.60 | $0.42 |
Earnings Per Share, Diluted | $0.59 | $0.42 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,566,993 | 3,374,995 |
Other_Comprehensive_Income_Los2
Other Comprehensive Income (Loss) (Details) (USD $) | 3 Months Ended | |||
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | ||
Equity [Abstract] | ||||
Cumulative translation adjustments, before-tax | ($340) | ($39) | ||
Cumulative translation adjustment, net-of-tax | -352 | -43 | ||
Pension and other benefits: | ||||
Net actuarial gains (losses) and prior service costs arising during the period, before-tax | -1 | 3 | ||
Net actuarial gains (losses) and prior service costs arising during the period, net-of-tax | -1 | 2 | ||
Amortization of net actuarial loss, transition & prior service costs, before-tax | 22 | [1] | 14 | [1] |
Amortization of net actuarial loss, transition & prior service costs, net-of-tax | 14 | [1] | 11 | [1] |
Retirement Plan and other retiree benefit adjustments, before-tax | 21 | 17 | ||
Retirement Plan and other retiree benefit adjustments, net-of-tax | 13 | 13 | ||
Available-for-sale securities: | ||||
Unrealized gains (losses) on available-for-sale securities, before-tax | -1 | [2] | -298 | [2] |
Unrealized gains (losses) on available-for-sale securities, net-of-tax | -1 | [2] | -194 | [2] |
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax | 0 | [3] | 211 | [3] |
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax | 0 | [3] | 138 | [3] |
Gains (losses) on available-for-sale securities, before-tax | -1 | -87 | ||
Gains (losses) on available-for-sale securities, net-of-tax | -1 | -56 | ||
Cash flow hedges: | ||||
Unrealized gains (losses) on cash flow hedges, before-tax | 6 | 2 | ||
Unrealized gains (losses) on cash flow hedges, net-of-tax | 4 | 1 | ||
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax | -6 | [4] | -3 | [4] |
Reclassification of (gains) losses into net earnings on cash flow hedges, net-of-tax | -4 | [4] | -1 | [4] |
Gains (losses) on cash flow hedges, before-tax | 0 | -1 | ||
Gains (losses) on cash flow hedges, net-of-tax | 0 | 0 | ||
Total other comprehensive income (loss), before-tax | -320 | -110 | ||
Total other comprehensive income (loss), net-of-tax | -340 | -86 | ||
Remeasurement Due To Change in Foreign Exchange Rates [Abstract] | ||||
Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela | $276 | |||
[1] | These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details. | |||
[2] | For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014. | |||
[3] | Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014. See Note 13, Fair Value Measurements and Financial Instruments for additional details. | |||
[4] | These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details. |
Retirement_Plans_and_Other_Ret2
Retirement Plans and Other Retiree Benefits (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
United States Pension Benefits [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Voluntary benefit plan contribution | $0 | $0 |
Components of net periodic benefit cost | ||
Service cost | 0 | 0 |
Interest cost | 25 | 25 |
Expected return on plan assets | -29 | -27 |
Amortization of transition and prior service costs (credits) | 0 | 0 |
Amortization of actuarial loss (gain) | 12 | 8 |
Net periodic benefit cost | 8 | 6 |
International Pension Benefits [Member] | ||
Components of net periodic benefit cost | ||
Service cost | 5 | 5 |
Interest cost | 8 | 9 |
Expected return on plan assets | -8 | -7 |
Amortization of transition and prior service costs (credits) | 0 | 1 |
Amortization of actuarial loss (gain) | 3 | 1 |
Net periodic benefit cost | 8 | 9 |
Other Retiree Benefits [Member] | ||
Components of net periodic benefit cost | ||
Service cost | 4 | 3 |
Interest cost | 11 | 10 |
Expected return on plan assets | -1 | 0 |
Amortization of transition and prior service costs (credits) | 0 | 0 |
Amortization of actuarial loss (gain) | 7 | 4 |
Net periodic benefit cost | $21 | $17 |
Contingencies_Details
Contingencies (Details) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2015 |
country_and_territory | |
Loss Contingency [Abstract] | |
Minimum Number Of Countries And Territories Serving Consumers | 200 |
Range of reasonably possible losses, minimum | $0 |
Range of reasonably possible losses, maximum | 200 |
Brazilian internal revenue authority, matter 1 | 90 |
Brazilian internal revenue authority, matter 2 | 55 |
European competition matters - Swiss competition law authority | 6 |
European competition matters - Spanish competition law authority | 3 |
European competition matters - Italian competition law authority | 3 |
Fine Imposed French Competition Authority | 57 |
Fine Imposed French Competition Authority - As a result of Sanex Acquisition | 25 |
European competition matters - Hill's France Subsidiary | $7 |
Segment_Information_Details
Segment Information (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Segment Reporting Information [Line Items] | ||
Total Net sales | $4,070 | $4,325 |
Total Operating profit | 860 | 634 |
MEXICO | ||
Segment Reporting Information [Line Items] | ||
Pretax costs related to sale of land | 0 | 1 |
Operating Segments [Member] | Oral, Personal and Home Care [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 3,532 | 3,772 |
Total Operating profit | 942 | 975 |
Operating Segments [Member] | Pet Nutrition [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 538 | 553 |
Total Operating profit | 147 | 144 |
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 789 | 785 |
Total Operating profit | 218 | 216 |
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 1,087 | 1,152 |
Total Operating profit | 308 | 290 |
Operating Segments [Member] | Europe/South Pacific [Member] | Oral, Personal and Home Care [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 741 | 865 |
Total Operating profit | 184 | 217 |
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 661 | 672 |
Total Operating profit | 193 | 193 |
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Net sales | 254 | 298 |
Total Operating profit | 39 | 59 |
Corporate, Non-Segment [Member] | ||
Segment Reporting Information [Line Items] | ||
Total Operating profit | -229 | -485 |
Two Thousand Twelve Restructuring Program [Member] | ||
Segment Reporting Information [Line Items] | ||
Pretax Charges Related To The Restructuring Program | 100 | 102 |
Sales Revenue, Net [Member] | ||
Segment Reporting Information [Line Items] | ||
Percentage of Consolidated Net Sales represented by Sales outside US | 80.00% | |
Percentage of Consolidated Net Sales coming from Emerging Markets | 50.00% | |
CP Venezuela [Member] | ||
Segment Reporting Information [Line Items] | ||
Venezuela Remeasurement Charges | $266 |
Fair_Value_Measurements_and_Fi2
Fair Value Measurements and Financial Instruments (Details 1) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 | Mar. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||||
Designated derivative instruments | ||||
Derivative Assets | $174 | $94 | ||
Derivative Liabilities | 19 | 7 | ||
Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||||
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value | 13 | 8 | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | 0 | 0 | ||
Total assets derivatives | 187 | 102 | ||
Total liabilities derivatives | 19 | 7 | ||
Financial Instruments, Owned, at Fair Value [Abstract] | ||||
Total other financial instruments | 690 | 564 | ||
Bonds Issued By Venezuelan Government [Member] | ||||
Financial Instruments, Owned, at Fair Value [Abstract] | ||||
Available-for-sale Securities, Fair Value Disclosure | 431 | 399 | 441 | 685 |
Other Current Assets [Member] | ||||
Financial Instruments, Owned, at Fair Value [Abstract] | ||||
Marketable Securities | 250 | 200 | ||
Notes Receivable, Fair Value Disclosure | 42 | 42 | ||
Other Current Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member] | ||||
Financial Instruments, Owned, at Fair Value [Abstract] | ||||
Marketable Securities | 33 | |||
Interest Rate Swap Contracts [Member] | Other Current Assets [Member] | ||||
Designated derivative instruments | ||||
Derivative Assets | 1 | 1 | ||
Interest Rate Swap Contracts [Member] | Other accruals [Member] | ||||
Designated derivative instruments | ||||
Derivative Liabilities | 0 | 0 | ||
Interest Rate Swap Contracts [Member] | Other Assets [Member] | ||||
Designated derivative instruments | ||||
Derivative Assets | 16 | 12 | ||
Interest Rate Swap Contracts [Member] | Other Liabilities [Member] | ||||
Designated derivative instruments | ||||
Derivative Liabilities | 0 | 2 | ||
Foreign Currency Contracts [Member] | Other Current Assets [Member] | ||||
Designated derivative instruments | ||||
Derivative Assets | 36 | 21 | ||
Foreign Currency Contracts [Member] | Other accruals [Member] | ||||
Designated derivative instruments | ||||
Derivative Liabilities | 18 | 4 | ||
Foreign Currency Contracts [Member] | Other Assets [Member] | ||||
Designated derivative instruments | ||||
Derivative Assets | 121 | 60 | ||
Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||||
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value | 13 | 8 | ||
Foreign Currency Contracts [Member] | Other Liabilities [Member] | ||||
Designated derivative instruments | ||||
Derivative Liabilities | 0 | 0 | ||
Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | 0 | 0 | ||
Commodity Contracts [Member] | Other Current Assets [Member] | ||||
Designated derivative instruments | ||||
Derivative Assets | 0 | 0 | ||
Commodity Contracts [Member] | Other accruals [Member] | ||||
Designated derivative instruments | ||||
Derivative Liabilities | 1 | 1 | ||
Estimate of Fair Value Measurement [Member] | Other Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member] | ||||
Financial Instruments, Owned, at Fair Value [Abstract] | ||||
Available-for-sale Securities, Fair Value Disclosure | $398 | $322 |
Fair_Value_Measurements_and_Fi3
Fair Value Measurements and Financial Instruments (Details 2) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Millions, unless otherwise specified | ||
Carrying Value [Member] | ||
Debt Instrument [Line Items] | ||
Carrying value of long-term debt | $6,110 | $6,132 |
Fair Value, Inputs, Level 2 [Member] | ||
Debt Instrument [Line Items] | ||
Estimated fair value of long-term debt | $6,463 | $6,346 |
Fair_Value_Measurements_and_Fi4
Fair Value Measurements and Financial Instruments (Details 3) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | $102 | $96 |
Activity related to derivatives not designated as hedging instruments [Abstract] | ||
Gain (loss) on instrument | 5 | -1 |
Gain (loss) on hedged item | -5 | 1 |
Fair Value Hedging [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 2,651 | 2,369 |
Activity related to fair value hedges [Abstract] | ||
Gain (loss) on derivative | 8 | -8 |
Gain (loss) on hedged items | -8 | 8 |
Fair Value Hedging [Member] | Foreign Currency Contracts [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 1,213 | 681 |
Activity related to fair value hedges [Abstract] | ||
Gain (loss) on derivative | 2 | 2 |
Gain (loss) on hedged items | -2 | -2 |
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 1,438 | 1,688 |
Activity related to fair value hedges [Abstract] | ||
Gain (loss) on derivative | 6 | -10 |
Gain (loss) on hedged items | -6 | 10 |
Cash Flow Hedging [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 607 | 416 |
Activity related to cash flow hedges [Abstract] | ||
Gain (loss) recognized in OCI | 6 | 2 |
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 595 | 401 |
Activity related to cash flow hedges [Abstract] | ||
Gain (loss) recognized in OCI | 7 | 0 |
Cash Flow Hedging [Member] | Commodity Contracts [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 12 | 15 |
Activity related to cash flow hedges [Abstract] | ||
Gain (loss) recognized in OCI | -1 | 2 |
Net Investment Hedging [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 1,041 | 936 |
Activity related to net investment hedges [Abstract] | ||
Gain (loss) on instruments | 89 | 1 |
Gain (loss) on hedged items | -89 | 0 |
Net Investment Hedging [Member] | Foreign Currency Contracts [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 768 | 680 |
Activity related to net investment hedges [Abstract] | ||
Gain (loss) on instruments | 62 | 0 |
Gain (loss) on hedged items | -62 | 1 |
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member] | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Derivative, Notional Amount | 273 | 256 |
Activity related to net investment hedges [Abstract] | ||
Gain (loss) on instruments | 27 | 1 |
Gain (loss) on hedged items | -27 | -1 |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | ||
Activity related to cash flow hedges [Abstract] | ||
Gain (loss) reclassified into Cost of sales | 6 | 3 |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | Foreign Currency Contracts [Member] | ||
Activity related to cash flow hedges [Abstract] | ||
Gain (loss) reclassified into Cost of sales | 7 | 2 |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | Commodity Contracts [Member] | ||
Activity related to cash flow hedges [Abstract] | ||
Gain (loss) reclassified into Cost of sales | ($1) | $1 |
Fair_Value_Measurements_and_Fi5
Fair Value Measurements and Financial Instruments (Details 4) (USD $) | 3 Months Ended | |||
In Millions, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 |
Schedule of Available-for-sale Securities [Line Items] | ||||
Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela | $276 | |||
Bonds Issued By Venezuelan Government [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Available-for-sale Securities | 441 | 431 | 399 | 685 |
Other Current Assets [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Marketable Securities | 250 | 200 | ||
Fair Value, Inputs, Level 1 [Member] | Other Current Assets [Member] | Deposits [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Marketable Securities | 217 | |||
Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Fair Value of U.S. dollar-linked, devaluation-protected bonds | 72 | |||
Fair Value of fixed interest rate bonds | 359 | |||
Fair Value, Inputs, Level 2 [Member] | Other Current Assets [Member] | Bonds Issued By Venezuelan Government [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Marketable Securities | 33 | |||
Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member] | Other Assets [Member] | Bonds Issued By Venezuelan Government [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Available-for-sale Securities | $398 | $322 |
Fair_Value_Measurements_and_Fi6
Fair Value Measurements and Financial Instruments (Details 5) (Bonds Issued By Venezuelan Government [Member], USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Bonds Issued By Venezuelan Government [Member] | ||
Venezuelan Investments [Roll Forward] | ||
Beginning balance | $399 | $685 |
Unrealized gain (loss) on investment | -1 | -298 |
Purchases and sales during the period | 33 | 54 |
Ending balance | $431 | $441 |
Venezuela_Details
Venezuela (Details) | 3 Months Ended | 3 Months Ended | ||||
In Millions, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2015 | Mar. 31, 2015 | Mar. 31, 2015 |
USD ($) | USD ($) | CP Venezuela [Member] | CP Venezuela [Member] | CP Venezuela [Member] | VENEZUELA | |
USD ($) | USD ($) | Sales Revenue, Net [Member] | VEF | |||
Foreign Currency [Line Items] | ||||||
Official Exchange Rate | 6.3 | |||||
SICAD Exchange Rate | 12 | |||||
SIMADI Exchange Rate | 192.95 | |||||
Pretax Remeasurement Charge | $0 | $266 | $266 | |||
Aftertax Remeasurement Charge | 174 | |||||
Impact of Aftertax Remeasurement Charge Per Common Share, Diluted | $0.19 | |||||
Percentage of consolidated Net sales represented by CP Venezuela | 4.00% | |||||
Bolivar fuerte denominated monetary net asset position | 589 | |||||
Bolivar Fuerte denominated non monetary asset position | 302 | |||||
Bolivar Fuerte Denominated Non Monetary Fixed Asset Position | 234 | |||||
Total Investment in CP Venezuela Including Intercompany Payables | $987 |